Kansas City Dermatology, PA — Overland Park, Kansas

Kansas City Dermatology, PA is a clinical research site located in Overland Park, Kansas, United States 66215.

Crixeo Health Trust Score: 79/100 (FAIR). This profile has not yet been claimed by the site owner.

Kansas City Dermatology, PA has participated in 17 clinical trials.

Therapeutic areas: Plaque Psoriasis, Atopic Dermatitis, Dermatitis, Atopic.

Sponsors: Eli Lilly and Company, LEO Pharma, AnaptysBio, Inc..

Sponsor Feasibility Report

Trust Score: 79/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Kansas City Dermatology, PA?

Kansas City Dermatology, PA has a Crixeo Trust Score of 79/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Kansas City Dermatology, PA conducted?

Kansas City Dermatology, PA has 17 clinical trials on record. Their work covers Plaque Psoriasis, Atopic Dermatitis, Dermatitis, Atopic.

Is Kansas City Dermatology, PA accredited by Crixeo Health?

Yes — Kansas City Dermatology, PA holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.

Can I submit a review or complaint about Kansas City Dermatology, PA?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.